首页> 外文期刊>Frontiers in Cardiovascular Medicine >Therapeutic Decision-Making and Outcomes in Elderly Patients With Severe Symptomatic Aortic Stenosis: Prognostic Implications of Elderly Patients' Initial Decisions
【24h】

Therapeutic Decision-Making and Outcomes in Elderly Patients With Severe Symptomatic Aortic Stenosis: Prognostic Implications of Elderly Patients' Initial Decisions

机译:严重症状主动脉狭窄的老年患者治疗决策和结果:老年患者初步决策的预后意义

获取原文
           

摘要

Background: Despite clear indications for intervention, therapeutic decision-making for elderly patients with severe symptomatic aortic stenosis (AS) remains a complex issue due to the wide variation in individual risk profiles and the involvement of patients' subjective preferences. We aimed to investigate the reasons leading to the decisions against intervention and the consequences thereof on survival. Methods: Data were derived from the China Elderly Valve Disease (China-DVD) Cohort Study on patients aged ≥60-year-old with severe symptomatic AS consecutively enrolled between September to December 2016. Patients were analyzed according to the initial therapeutic decisions made by consensus between patients and physicians at the time of the index evaluation: intervention group (patients who were evaluated as suitable for intervention and accepted the treatment proposal); patient-refusal group (patients who were evaluated as suitable for intervention but refused due to subjective preferences); physician-deny group (patients who were denied intervention by physicians after evaluation). The least absolute shrinkage and selection operator (LASSO)-penalized logistic regression model was used to identify the factors associated with physicians' decisions against intervention. Twelve-month survival was analyzed using Cox proportional hazards models, with multivariate adjustment using inverse probability weighting (IPW). Results: Among the enrolled 456 elderly patients with severe symptomatic AS, 52 (11.4%) patients refused intervention and 49 (10.7%) patients were denied intervention by their physicians. LASSO-penalized logistic regression model identified that reduced left ventricular ejection fraction and increased EuroSCORE-II were strongly associated with physicians' decisions against intervention. At 12-month follow-up, only 8 (15.4%) patients who initially refused the intervention proposal underwent the subsequent intervention, with an average delay of 195 days. Patients' initial decisions against intervention were significantly associated with 12-month mortality, even after IPW adjustment (Hazard ratio: 2.61; 95% confidence interval: 1.09–6.20; P = 0.031). Conclusions: The decision against intervention was taken in about one-fifth of elderly patients with symptomatic severe AS, half of which were due to patients' subjective preferences. Surgical risk remains the primary concern for physicians when making therapeutic decisions. Elderly patients' initial decisions against intervention have a profound impact on subsequent intervention rates and prognosis, and therefore should be treated as a “risk factor” at the subjective level. Clinical Trial Registration: clinicaltrials.gov/ct2/show/ {"type":"clinical-trial","attrs":{"text":"NCT02865798","term_id":"NCT02865798"}} NCT02865798 , China elDerly Valve Disease (China-DVD) cohort study ( {"type":"clinical-trial","attrs":{"text":"NCT02865798","term_id":"NCT02865798"}} NCT02865798 ).
机译:背景技术:尽管有明确的干预迹象,但由于个体风险概况的广泛变化和患者主观偏好的涉及,老年症状主动脉狭窄的老年患者的治疗决策仍然是一个复杂的问题。我们旨在调查导致措施与干预措施的原因及其在生存中的后果。方法:源自中国老年阀门病(中国DVD)队列的数据,≥60岁的患者患者≥60岁,令人严重的症状,如2016年9月至12月在2016年12月之间均等。根据初始治疗决定分析患者指数评价时患者和医生之间的共识:干预组(评估适合干预并接受治疗提案的患者);患者拒绝组(评估为适用于干预但由于主观偏好而拒绝的患者);医师拒绝组(评估后受到医师干预的患者)。绝对收缩和选择运营商(套索) - 级逻辑回归模型用于识别与医生对干预的决定相关的因素。使用Cox比例危险模型分析了12个月的生存,使用反向概率加权(IPW)进行多变量调整。结果:在注册的456名老年患者中,患有52名(11.4%)拒绝干预的患者,49名(10.7%)患者被医生拒绝干预。左旋损益的逻辑回归模型确定,减少左心室喷射部分和欧迈斯科·二世的增加与医生对干预的决定强烈关联。在12个月的随访中,只有8名(15.4%)患者最初拒绝干预建议的后续干预,平均延误195天。患者对干预的初步决定与12个月的死亡率有显着相关,即使在IPW调整后(危险比:2.61; 95%置信区间:1.09-6.20; P = 0.031)。结论:对患有症状严重的症状患者的大约五分之一的患者患有止血的决定是由于患者的主观偏好。在制定治疗决策时,外科风险仍然是医生的主要问题。老年患者对干预的初步决策对随后的干预率和预后的影响深刻影响,因此应在主观层面视为“危险因素”。临床试验注册:ClinicalTrials.gov/ct2/show/ {“类型”:“临床试验”,“attrs”:{“text”:“nct02865798”,“term_id”:“nct02865798”nct02865798“} NCT02865798,中国老年阀门NCT02865798疾病(中国DVD)队列研究({“类型”:“临床试验”,“attrs”:{“text”:“nct02865798”,“term_id”:“nct02865798”nct02865798)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号